Searching 'weight' can bring up Ozempic in results. It's a drug advertising loophole

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Novo Nordisk A/S: Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues

Operating profit increased by 5% in Danish kroner and 10% at constant exchange rates (CER) to DKK 95.9 billion, impacted by one-off restructuring costs of around DKK 9 billion related to the ...
PharmExec

Novo Nordisk Stock Reacts to Recent Board Changes

Novo Nordisk's board changes stem from disagreements with the Novo Nordisk Foundation over board composition and strategic ...

Novo Nordisk’s new ‘king’ tightens his grip at obesity drug giant

The overhaul comes after the foundation ousted former chief executive Lars Fruergaard Jørgensen in May, blaming him for an ...
Morningstar

Novo Nordisk: Lower 2025 Guidance Reflects Persistent Competition from Compounded Semaglutide

Novo Nordisk NVO saw 18% sales growth and 40% operating profit growth at constant currencies in the second quarter, but management reduced 2025 guidance to 8%-14% sales growth and 10%-16% ...
PharmExec

Novo Nordisk Announces Major Shake Ups to Board

Novo Nordisk will hold an Extraordinary General Meeting to elect new board members due to a disagreement with the Foundation over board composition. Key board members, including Chair Helge Lund, will ...